Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Malignant Solid Tumor × Ribavirin × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Malignant Solid Tumor 1

Interventions

pembrolizumab 3 Ramucirumab 2 etirinotecan pegol 1 cemiplimab 1 Ribavirin 1 Paclitaxel 1 Nivolumab 1 Injections 1 Fluorouracil 1 Docetaxel 1 Decitabine 1 Cisplatin 1 Carboplatin 1 Antibodies, Bispecific 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01309490 2025-07-29

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Jewish General Hospital

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡